Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

Prospective Multicenter Study Evaluating Fecal Calprotectin in Adult Acute Bacterial Diarrhea

(2008) Yogesh M. Shastri et al.   AMERICAN JOURNAL OF MEDICINE

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease

(2008) Jennifer Jones et al.   Clinical Gastroenterology and Hepatology

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

(2008) Michael Wagner et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

(2007) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES